[-] Show simple item record

dc.contributor.authorReilly, Philipeng
dc.contributor.authorJankowski, Terry Ann, 1951-eng
dc.contributor.authorFotinos, Charissaeng
dc.date.issued2011eng
dc.description.abstractYes, if the pneumococcal conjugate vaccine (PCV) series is given before 12 months of age. Vaccination before 12 months is associated with a statistically significant reduction in the incidence of both acute (AOM) and recurrent (ROM) otitis media (strength of recommendation [SOR]: A, a systematic review of randomized controlled trials [RCTs] and a large retrospective cohort trial). The benefit disappears if the series is started after 12 months (SOR: B, a systematic review of RCTs with inconsistent results). PCV reduces tympanostomy tube placement for ROM (SOR: A, a large RCT and retrospective cohort trials).eng
dc.identifier.urihttp://hdl.handle.net/10355/11371eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2011 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 60, no. 08 (August 2011): 488-489.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectinfection preventioneng
dc.subject.lcshEar -- Infections -- Treatmenteng
dc.titleDoes pneumococcal conjugate vaccine prevent otitis media?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record